REG - Atlantic Lithium Ltd - Lapse of PDMR Options

Atlantic LithiumAnnouncement

04/04/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250404:nRSD6535Da&default-theme=true

RNS Number : 6535D  Atlantic Lithium Limited  04 April 2025

4 April 2025

Lapse of PDMR Options

The Board of Atlantic Lithium Limited (AIM: ALL, ASX: A11, GSE: ALLGH, OTCQX:
ALLIF, "Atlantic Lithium" or the "Company"), the Africa-focused lithium
exploration and development company targeting the delivery of Ghana's first
lithium mine, provides notice of changes to directors' interests in accordance
with ASX listing rule 3.19A.2, and as agent for the following directors for
the purposes of section 205G of the Corporations Act 2001 (Cth):

-      Neil Herbert:

o  Lapse of 2,000,000 Options over new ordinary shares of no par value each
with an exercise price £0.60 which expired on 31 March 2025

-      Amanda Harsas:

o  Lapse of 2,000,000 Options over new ordinary shares of no par value each
with an exercise price £0.60 which expired on 31 March 2025

Following the lapse of the above options, the number of securities held by
Executive Directors of the Company is as follows:

 Executive Director                                       No. of Securities Held
 Neil Herbert, Executive Chairman                         8,671,522 Ordinary Shares

                                                          372,416 Performance Rights(1) - vested

                                                          1,117,247 Performance Rights(2) - vesting date 31 July 2025

                                                          1,263,349 Performance Rights(2) - vesting date 31 July 2026

                                                          1,680,640 Performance Rights(2) - vesting date 31 July 2027
 Keith Muller, Chief Executive Officer                    765,217 Ordinary Shares

                                                          2,000,000 Options exercise price £0.50 expiry on 16 May 2025

                                                          653,160 Performance Rights(2) - vesting date 31 July 2025

                                                          816,450 Performance Rights(2) - vesting date 31 July 2026

                                                          1,086,128 Performance Rights(2) - vesting date 31 July 2027
 Amanda Harsas, Finance Director & Company Secretary      4,500,000 Ordinary Shares

                                                          229,179 Performance Rights(1) - vested

                                                          687,537 Performance Rights(2) - vesting date 31 July 2025

                                                          756,290 Performance Rights(2) - vesting date 31 July 2026

                                                          1,006,098 Performance Rights(2) - vesting date 31 July 2027

1.   The vested Performance Rights can be converted to fully paid ordinary
shares in the Company (Shares) upon the exercise of the vested Performance
Rights by the holders at any time. Notice of vesting has been provided to the
Performance Rights holders. The Company will notify the market of the issue of
Shares upon exercise of vested Performance Rights.

2.   The Performance Rights not yet vested are subject to performance and
vesting conditions as set by the Board and approved by Shareholders.

Authorised for release by Amanda Harsas, Finance Director and Company
Secretary, Atlantic Lithium Limited.

 

For any further information, please contact:
Atlantic Lithium Limited

Neil Herbert (Executive Chairman)

Amanda Harsas (Finance Director and Company Secretary)

                   www.atlanticlithium.com.au
                   IR@atlanticlithium.com.au
                   Tel: +61 2 8072 0640
 SP Angel Corporate Finance LLP      Yellow Jersey PR Limited                                           Canaccord Genuity Limited

 Nominated Adviser                   Charles Goodwin                                                    Financial Adviser:

 Jeff Keating                        Bessie Elliot                                                      Raj Khatri (UK) /

                                   atlantic@yellowjerseypr.com (mailto:atlantic@yellowjerseypr.com)

 Charlie Bouverat
                                                                  Duncan St John, Christian Calabrese (Australia)

                                   Tel: +44 (0)20 3004 9512

 Tel: +44 (0)20 3470 0470

                                                                                                        Corporate Broking:

                                                                                                        James Asensio

                                                                                                        Tel: +44 (0) 20 7523 4500

 

Notes to Editors:

About Atlantic Lithium

www.atlanticlithium.com.au (http://www.atlanticlithium.com.au/)

Atlantic Lithium is an AIM, ASX, GSE and OTCQX-listed lithium company
advancing its flagship project, the Ewoyaa Lithium Project, a significant
lithium spodumene pegmatite discovery in Ghana, through to production to
become the country's first lithium-producing mine.

The Project was awarded a Mining Lease in October 2023, an Environmental
Protection Agency ("EPA") Permit in September 2024, and a Mine Operating
Permit in October 2024 and is being developed under an earn-in agreement with
Piedmont Lithium Inc.

Atlantic Lithium holds a portfolio of lithium projects within 509km(2) and
771km(2) of granted and under-application tenure across Ghana and Côte
d'Ivoire respectively, which, in addition to the Project, comprises
significantly under-explored, highly prospective licences.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHUSUORVOUSRRR